Year All News20222021 Oct 4 2021 MoonLake Immunotherapeutics AG and Helix Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing Tri-specific Nanobody® Sonelokimab Read More + Aug 10 2021 MoonLake Immunotherapeutics appoints former Kymab CEO Simon Sturge as Chairman and Spike Loy to the Board of Directors Read More + Jul 1 2021 MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO Read More + May 6 2021 MoonLake Immunotherapeutics announces publication in The Lancet Read More + May 3 2021 MoonLake In-licensing and launch Read More +
Oct 4 2021 MoonLake Immunotherapeutics AG and Helix Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing Tri-specific Nanobody® Sonelokimab Read More +
Aug 10 2021 MoonLake Immunotherapeutics appoints former Kymab CEO Simon Sturge as Chairman and Spike Loy to the Board of Directors Read More +
Jul 1 2021 MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO Read More +
MoonLake
